Valley National Advisers’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
MC
FHA
AAM
1CP
Valley National Advisers's HQL Position: Q2 2020 in Review
Valley National Advisers sold out of abrdn Life Sciences Investors (HQL) in Q2 2020, closing a stake of 644 shares — an estimated $10K sold.
Valley National Advisers first reported a position in HQL in Q4 2014 and held it in 22 quarters. The position peaked at $91K in Q2 2015. 70 funds tracked by Wall St. Rank hold HQL as of Q2 2020.
- Valley National Advisers reported no remaining abrdn Life Sciences Investors position as of Q2 2020 after selling out during the quarter.
- Valley National Advisers sold 644 abrdn Life Sciences Investors shares in Q2 2020, an estimated $10K.
- Valley National Advisers first reported a position in abrdn Life Sciences Investors in Q4 2014 and held it in 22 quarters.
- Valley National Advisers's abrdn Life Sciences Investors position peaked at $91K in Q2 2015.
- 70 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2020.
Based on Valley National Advisers's 13F filing for Q2 2020, filed 10 Aug 2020.